- Zacks•3 days ago
Supernus Pharmaceuticals, Inc. (SUPN) announced that the FDA has granted a tentative approval to the company's sNDA for a label expansion for Trokendi XR to include prophylaxis of migraine headache in adults.
- Zacks•14 days ago
Adverum (ADVM) reported a narrower-than-expected loss in the second quarter. The company also decided to discontinue the development of lead candidate.
Pacira Pharmaceuticals, Inc. (PCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||39.50 x 1500|
|Ask||55.79 x 100|
|Day's Range||39.61 - 43.83|
|52wk Range||31.08 - 80.25|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-128.17|
|Avg Vol (3m)||829,260|
|Dividend & Yield||N/A (N/A)|